A postdoc at the Oklahoma Medical Research Foundation faked data in a submitted paper and in a grant application, according to a new report from the Office of Research Integrity.
Bin Kang admitted to the misconduct, in which he Continue reading Oklahoma postdoc admits to faking data in grant application, submitted paper
Tyndale House says it will be recalling copies of The Boy Who Came Back from Heaven after the boy in question, Alex Malarkey (yes, that’s really his name), said he didn’t make the trip after all.
Malarkey made the claim after having been injured in a car accident when he was 6. The book became a best-seller for Tyndale, which, according to NPR, called it Continue reading Heaven still waiting: Publisher pulls book after boy recants on visit to heaven
A graduate student at the University of Colorado Denver faked data in his work at a drug research lab that has notched two retractions and an expression of concern over “data integrity,” according to an extensive university investigation.
It seems like many more retractions are on the horizon for grad student Rajendra Kadam, who worked in the lab of Uday Kompella, a pharmaceutical researcher at the university.
Here’s an excerpt from the report, which you can read in full (but redacted) here: Continue reading U Colorado “golden boy” grad student faked data in drug lab, says investigation
Two researchers who already had three expressions of concern under their belts have five more, plus a retraction.
Kelly Wiggins and Christopher Bielawski share authorship on all the papers in question. After the first set of EoCs, Bielawski, at the time a PI at UT Austin, told Chemistry and Engineering News that a “former lab member” had admitted to faking the data. The recent retraction indicates that University of Texas at Austin’s Office of Research Integrity formally investigated the lab, and determined that Bielawski was telling the truth about a former lab member being to blame.
Bielawski has since taken a post at Ulsan National Institute of Science and Technology in South Korea. He told us that move was unrelated to anything that happened at UT Austin, but declined to answer other questions. Wiggins got a postdoc at the University of Illinois, which an Illinois spokesperson confirmed lasted from July 1 2013 to January 22 2014; we’re waiting to hear back on our question about whether her departure had anything to do with misconduct.
Here’s the retraction notice for “A Mechanochemical Approach to Deracemization,” in Wiley journal Angewandte Chemie: Continue reading Chemists Bielawski and Wiggins up to eight expressions of concern, one retraction
Several months after a drug company cancelled development of a potential diabetes cure because it found evidence that a biotech they had recently acquired had committed misconduct in studies of the drug, two retractions of relevant studies have appeared.
The research involves DiaPep277, which, as Josh Levy explained here in September, “would cause the immune system to stop attacking beta cells,” the cells in the pancreas that produce insulin. But Hyperion Therapeutics, which had acquired DiaPep277 developer Andromeda Biotech in June, announced in September that it had
uncovered evidence that certain employees of Andromeda Biotech, Ltd., which Hyperion acquired in June 2014, engaged in serious misconduct, including collusion with a third-party biostatistics firm in Israel to improperly receive un-blinded DIA-AID 1 trial data and to use such data in order to manipulate the analyses to obtain a favorable result.
The retractions are both of papers published in Diabetes Care in May 2014. Here’s the notice for “Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial:” Continue reading Retractions follow revelations of misconduct by diabetes biotech
Retired Dutch anthropologist Mart Bax made a career out of making up papers, many of them on the Bosnian genocide.
He retired from the Free University in Amsterdam in 2002. It wasn’t until 2013 that the university published a report indicating that Bax never published 61 of the papers he listed on his CV, and many of the real articles were based on fabricated data.
Publisher Taylor and Francis retracted one of Bax’s papers from Ethnic and Racial Studies in April. Now they’re retracting a second, from Ethnos, using almost identical language.
Here’s the notice: Continue reading Second retraction appears for Mart Bax
Three doctors at the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh are losing a paper based on phone calls to the Drug Information Unit, a phone line that patients could call to learn more about the drugs they were considering taking.
The catch: It was all made up.
According to an investigation by the Hindustan Times, the phone was disconnected between 2012 and May 2014, though ‘data’ for the paper was allegedly collected in 2013. We imagine that would make it difficult to answer the 56 calls the paper claims a junior resident took over the course of a month.
The HT reports that the Journal of Clinical & Diagnostic Research paper, “Drug Information Unit as an Effective Tool for Promoting Rational Drug Use,” is being retracted, and that the dean has asked for an official investigation. We’ve reached out to the journal, and will update with any new information.
This isn’t the worst of recent allegations against hospital staff at PGIMER. Orthopedics professor Vishal Kumar was accused of being in bed with pharmaceutical companies and harassing several employees. From the HT: Continue reading Hospital in India wracked by allegations of scientific misconduct, poor sanitation
Two Oxford journals have now put out three more retractions for ob-gyn and former University of Florida professor Nasser Chegini, who has been under ORI investigation since at least 2012. That makes a total of five retractions, by our count.
Here is the notice for “The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression” in Molecular Human Reproduction: Continue reading Three more retractions appear for Florida ob-gyn under investigation
Former University of Tokyo researcher Shigeaki Kato continues to put big numbers on the board.
Last month, we reported on his 26th, 27th, and 28th retractions, all in Nature Cell Biology and cited close to 700 times. Yesterday, EMBO Journal and EMBO Reports published a total of five more retractions for the endocrinology researcher, who resigned from the university in 2012 following investigations found he had faked images.
Here’s the notice for “A cell cycle-dependent co-repressor mediates photoreceptor cell-specific nuclear receptor function:” Continue reading Shigeaki Kato up to 33 retractions, with five papers cited a total of 450 times
A retraction has appeared for Jens Förster, the former University of Amsterdam social psychologist whose work has come under serious scrutiny by two official committees.
Here’s the notice for 2012’s “Sense Creative! The Impact of Global and Local Vision, Hearing, Touching, Tasting and Smelling on Creative and Analytic Thought,” a paper which first appeared in Social Psychological and Personality Science:
Continue reading Retraction appears for social psychologist Jens Förster